Phase I Study to Determine the Maximal Tolerated Dose and Dose-Limiting Toxicities of Orally Administered Idarubicin in Dogs with Lymphoma

D. M. Vail, B. D. Husbands, S. G. Kamerling, H. Simpson, I. D. Kurzman, A. McDonnell

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I Study to Determine the Maximal Tolerated Dose and Dose-Limiting Toxicities of Orally Administered Idarubicin in Dogs with Lymphoma'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences